Pressmeddelanden från Photocure

Bevaka pressreleaser

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway 03 mar 10:34

Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions 27 feb 10:17

Photocure partner Asieris announces that EMA has accepted Marketing Authorization Application for CEVIRA in Europe 18 feb 07:00

Photocure ASA: Results for the fourth quarter of 2025 11 feb 17:06

Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2025 financial results 12 jan 17:00

New publication of Hexvix trial data from China: blue light cystoscopy with Hexvix significantly improves the detection of bladder cancer using modern HD equipment 08 dec 2025 08:00

The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison 19 nov 2025 08:00

New budget impact model study in 4 European countries concludes that BLC use offers a clinically meaningful and economically rational approach to NMIBC management 31 okt 2025 08:24

Photocure ASA: Notification of primary insider transaction 29 okt 2025 07:00

Photocure ASA: Results for the third quarter of 2025 24 okt 2025 08:20

Photocure ASA: Invitation to presentation of third quarter 2025 financial results 15 okt 2025 17:08

Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy 22 sep 2025 08:23

Photocure ASA - Share option grant 04 aug 2025 14:39

Asieris: Cevira (APL-1702) NDA Advances to Second Round of Technical Review 30 jul 2025 07:00

Photocure ASA: Results for the second quarter of 2025 22 jul 2025 08:00

Photocure ASA: Invitation to presentation of second quarter and first half year 2025 financial results 23 jun 2025 14:55

Photocure ASA - Share option grant 08 maj 2025 07:00

Photocure ASA: Results for the first quarter of 2025 05 maj 2025 18:11

Photocure ASA: Annual general meeting held 30 apr 2025 20:57

Photocure ASA: Invitation to presentation of first quarter 2025 financial results 29 apr 2025 08:00

Bladder Cancer presentations at AUA2025: Blue Light Cystoscopy improves risk stratification and informed decision making 11 apr 2025 15:28

Photocure ASA - Notice of the Annual General Meeting 5 May 2025 11 apr 2025 15:19

Photocure ASA: Annual Report 2024 02 apr 2025 08:50

Photocure ASA: Transactions made under share buyback program 31 mar 2025 22:48

Photocure ASA: Transactions made under share buyback program 26 mar 2025 08:55

Photocure ASA - Share option grant to Vice President and General Manager EMEA 26 mar 2025 08:00

Photocure appoints Jane Healy as Vice President and General Manager EMEA 24 mar 2025 17:00

Clinical data presentations at the European Association of Urology (EAU) 2025 congress highlight the benefits of using Blue Light Cystoscopy in bladder cancer 19 mar 2025 18:00

Photocure ASA: Initiation of a share buyback 14 mar 2025 08:00

New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence 19 feb 2025 08:00

Photocure ASA: Results for the fourth quarter of 2024 17 feb 2025 17:00

News on Richard Wolf/Photocure Collaboration: Interim Flexible BLC solution available in countries where System blue and Richard Wolf reusable flexible cystoscopes are cleared 17 feb 2025 07:30

Bladder Cancer: Upstaging and risk mitigation with Blue Light Cystoscopy in NMIBC featured at ASCO GU 2025 12 feb 2025 14:27

Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2024 financial results 16 jan 2025 08:46

Photocure ASA: Transactions made under share buyback program 13 jan 2025 08:00

Photocure ASA: Transactions made under share buyback program 05 jan 2025 08:47

Photocure ASA: Transactions made under share buyback program 23 dec 2024 08:02

Photocure ASA - Share option grant 19 dec 2024 08:02

Photocure ASA: Initiation of a share buyback 03 dec 2024 15:14

Photocure ASA: Notification of primary insider transaction 03 dec 2024 07:00

Photocure ASA: Notification of primary insider transaction 13 nov 2024 08:00

Photocure ASA: Results for the third quarter of 2024 06 nov 2024 16:48

Photocure ASA: Invitation to presentation of third quarter 2024 financial results 05 nov 2024 10:34

Photocure Partner Asieris announces Marketing Approval by the National Medical Products Administration for Hexvix in China 30 sep 2024 08:00

Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting 27 sep 2024 08:00

Photocure establishes Named Patient Program to provide access to Hexvix in South Africa 17 sep 2024 12:09

Cevira (APL-1702): Photocure Partner Asieris Unveils Efficacy Data of Non-Surgical Treatment of Cervical HSIL at the 2024 PDT&PD Conference 07 aug 2024 08:00

Photocure ASA: Results for the second quarter of 2024 31 jul 2024 12:00

Photocure ASA: Invitation to presentation of second quarter and first half year 2024 financial results 15 jul 2024 17:52

Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization 04 jun 2024 08:00

Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.23 maj 2024 19:33

Photocure ASA – Annual general meeting held 15 maj 2024 08:00

Photocure ASA: Results for the first quarter of 2024 12 maj 2024 10:23

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China 08 maj 2024 22:36

Photocure ASA: Invitation to presentation of first quarter 2024 financial results 07 maj 2024 08:00

Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024 30 apr 2024 13:48

Photocure ASA – Notice of the Annual General Meeting 23 May 2024 30 apr 2024 11:52

Photocure ASA: Annual Report 2023 30 apr 2024 07:30

Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy 25 apr 2024 21:53

Photocure ASA – Share option grant 08 apr 2024 12:32

European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care 05 apr 2024 07:30

Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference 28 mar 2024 13:13

New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy 18 mar 2024 10:05

Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting 23 feb 2024 08:34

Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO 22 feb 2024 08:37

Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN 21 feb 2024 08:00

Photocure ASA: Results for the fourth quarter of 2023 19 feb 2024 09:29

Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2023 financial results 29 jan 2024 08:47

Photocure Partner Asieris presented clinical trial and real-world data on Hexvix in China at ASCO GU 2024 21 dec 2023 08:00

Photocure ASA – Share option grant 01 dec 2023 07:30

SUO 2023 Meeting: New Real World Evidence shows Significant Decrease in Risk of Bladder Cancer Recurrence with Blue Light Cystoscopy 29 nov 2023 10:05

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China 20 nov 2023 17:50

Photocure to present at four investor conferences in November/December 2023 08 nov 2023 08:00

Photocure ASA: Results for the third quarter of 2023 01 nov 2023 08:21

Photocure ASA: Invitation to presentation of third quarter 2023 financial results 12 okt 2023 10:32

Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress 07 okt 2023 08:00

Photocure Partner Asieris to present first results for its Hexvix Phase III clinical trial in China at the SIU 2023 Annual Meeting 06 okt 2023 15:07

New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines 27 sep 2023 18:05

Photocure ASA: Change of Board Composition 20 sep 2023 12:17

Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint 30 aug 2023 16:06

Photocure ASA: Notification of primary insider transaction 11 aug 2023 11:05

Photocure Partner Asieris confirms Hexvix Phase III clinical trial in China meets endpoint 09 aug 2023 08:00

Photocure ASA: Results for the second quarter and first half of 2023 03 aug 2023 08:13

Photocure ASA: Invitation to presentation of second quarter and first half year 2023 financial results 06 jul 2023 10:39

Photocure Partner Asieris announces completion of enrollment for Hexvix Phase III clinical trial in China 24 maj 2023 08:31

Photocure ASA – Share option grant 10 maj 2023 08:00

Photocure ASA: Results for the first quarter of 2023 04 maj 2023 13:22

Photocure ASA – Correction: Annual general meeting held 03 maj 2023 18:41

Photocure ASA – Annual general meeting held 03 maj 2023 11:38

Photocure ASA: Invitation to presentation of first quarter 2023 financial results 02 maj 2023 17:00

Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of Blue Light Cystoscopy 12 apr 2023 16:01

Photocure ASA – Notice of the Annual General Meeting 3 May 2023 12 apr 2023 16:01

Photocure ASA: Annual Report 2022 30 mar 2023 10:48

Photocure ASA – Share option grant 21 mar 2023 21:57

Photocure provides update on Karl Storz’s commitment to maximize the commercial adoption of Saphira™ and decision to discontinue flexible BLC tower production in the U.S.14 mar 2023 08:00

Photocure: New data presented at EAU 2023 highlight the effects of blue light cystoscopy in bladder cancer 23 feb 2023 08:00

Photocure ASA: Results for the fourth quarter of 2022 20 feb 2023 07:30

Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC 16 feb 2023 13:02

Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2022 financial results 03 jan 2023 07:30

New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursement